Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value of 0.01 per share
-
Shares outstanding
-
3.25M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
386K
-
Shares change
-
+151K
-
Total reported value, excl. options
-
$544K
-
Value change
-
+$194K
-
Number of buys
-
8
-
Number of sells
-
-2
-
Price
-
$1.41
Significant Holders of MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (MYNZ) as of Q2 2025
15 filings reported holding MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share as of Q2 2025.
MAINZ BIOMED N.V. - Ordinary Shares, nominal value of 0.01 per share (MYNZ) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 386K shares
of 3.25M outstanding shares and own 11.86% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (285K shares), Dauntless Investment Group, LLC (50K shares), Journey Advisory Group, LLC (15K shares), LPL Financial LLC (11.7K shares), Steward Partners Investment Advisory, LLC (10K shares), UBS Group AG (9.81K shares), Provenance Wealth Advisors, LLC (1.17K shares), OSAIC HOLDINGS, INC. (1.11K shares), MORGAN STANLEY (862 shares), and Newbridge Financial Services Group, Inc. (500 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.